Table 2.
Primary and secondary outcome parameters
| Topic & Instrument | Method | Patient | Patient | Patient | Clinician | Organisation |
|---|---|---|---|---|---|---|
| T0 | T1 | T2 | ||||
| Primary Outcome Parameter | ||||||
| Patient’s perception of SDM | ||||||
| Patient | ||||||
| Decisional Conflict Scale | SR | X | X | X | ||
| Secondary Outcome Parameter | ||||||
| Patient-clinician relationship | ||||||
| Patient | ||||||
| Working Alliance Inventory | SR | X | X | X | ||
| Clinician | ||||||
| Working Alliance Inventory (patient level) | SR | X (T2) | ||||
| Additional outcome measures | ||||||
| Compliance | ||||||
| Organization | ||||||
| Drop out (patient level) | EPR | X (T2) | ||||
| No-Show (patient level) | EPR | X (T2) | ||||
| Symptoms-functioning | ||||||
| Patient | ||||||
| OQ-45 | SR | X | X | X | ||
| Quality of life | ||||||
| Patient | ||||||
| MANSA-16 | SR | X | X | X | ||
SR self-report, EPR Electronical Patient Record
T0 = baseline
T1 = Follow-up +/−3 months after baseline (between 10 and 16 weeks)
T2 = +/−6 months after baseline (between 23 and 29 weeks)